Asia Pacific


2011 First Half Net Sales

01.08.2011 19:00

Sustained rebound in sales.

The Group rebounded strongly from the end of 2010 on renewed growth momentum in first half of this year. Sales were up 3% in Europe and 23% in other regions compared to last year, with significant sales growth for Lipiodol in the USA. Sales outside Europe accounted for 75% of the Group's growth.

Read the press release.